1-6 of 6
TL Smith
Close
Sort by
Journal Articles

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia

SM Kornblau, HJ Xu, W Zhang, SX Hu, M Beran, TL Smith, J Hester, E Estey, WF Benedict, AB Deisseroth
Journal: Blood
Blood (1994) 84 (1): 256–261.
https://doi.org/10.1182/blood.V84.1.256.256
Published: 1994
Journal Articles

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

HM Kantarjian, RS Walters, TL Smith, MJ Keating, B Barlogie, KB McCredie, EJ Freireich
Journal: Blood
Blood (1988) 72 (5): 1784–1789.
https://doi.org/10.1182/blood.V72.5.1784.1784
Published: 1988
Journal Articles

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

HM Kantarjian, TL Smith, KB McCredie, MJ Keating, RS Walters, M Talpaz, JP Hester, G Bligham, E Gehan, EJ Freireich
Journal: Blood
Blood (1985) 66 (6): 1326–1335.
https://doi.org/10.1182/blood.V66.6.1326.1326
Published: 1985
Journal Articles

Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)

MJ Keating, KB McCredie, RS Benjamin, GP Bodey, A Zander, TL Smith, EJ Freireich
Journal: Blood
Blood (1981) 58 (3): 584–591.
https://doi.org/10.1182/blood.V58.3.584.584
Published: 1981
Journal Articles

Pretreatment flow cytometry of DNA content in adult acute leukemia

GM Dosik, B Barlogie, TL Smith, EA Gehan, MJ Keating, KB McCredie, EJ Freireich
Journal: Blood
Blood (1980) 55 (3): 474–482.
https://doi.org/10.1182/blood.V55.3.474.474
Published: 1980
Journal Articles

Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxis

JP Litam, F Cabanillas, TL Smith, GP Bodey, EJ Freireich
Journal: Blood
Blood (1979) 54 (6): 1249–1257.
https://doi.org/10.1182/blood.V54.6.1249.1249
Published: 1979